Daniel Aghion - 04 Jan 2024 Form 4 Insider Report for ORAMED PHARMACEUTICALS INC. (ORMP)

Role
Director
Signature
/s/ Daniel Aghion
Issuer symbol
ORMP
Transactions as of
04 Jan 2024
Transactions value $
$0
Form type
4
Filing time
08 Jan 2024, 16:33:47 UTC
Previous filing
02 Jan 2024
Next filing
30 Jan 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ORMP Common Stock Award +30K 30K 04 Jan 2024 Direct F1
transaction ORMP Common Stock Award +5.07K +16.9% 35.1K 04 Jan 2024 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents Restricted Stock Units ("RSUs") that will vest in 3 installments as follows: 10,000 shall vest on each of January 1, 2025, January 1, 2026 and January 1, 2027. The RSUs convert into the Issuer's Common Stock on a one-for-one basis.
F2 Represents Restricted Stock Units ("RSUs") that will vest in quarterly installments of approximately 1,267 on April 1, 2024, July 1, 2024, October 1, 2024 and January 1, 2025. The RSUs convert into the Issuer's Common Stock on a one-for-one basis.